MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 11.02.2026
Organovo Holdings Kurzfristige Verbindlichkeiten 2011-2026 | ONVO
Kurzfristige Verbindlichkeiten Jährlich Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.74 M | 1.86 M | 3.67 M | 721 K | 1.81 M | 3.74 M | 4.66 M | 6.01 M | 4.49 M | 4.76 M | 1.89 M | 8.38 M | 22 M | 1.98 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22 M | 721 K | 4.98 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.71 B | $ 111.12 | -2.08 % | $ 33.8 B |  USA |
 |
Waters Corporation
WAT
|
1.24 B | $ 291.19 | -3.12 % | $ 17.3 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
250 M | $ 13.24 | -2.22 % | $ 3.76 B | USA |
 |
Exagen
XGN
|
14.2 M | $ 2.65 | -5.2 % | $ 57.1 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
|
Biodesix
BDSX
|
14.3 M | $ 14.32 | -1.92 % | $ 1.86 B | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
22.9 M | $ 1.14 | -0.59 % | $ 6.21 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 16.25 | -12.16 % | $ 174 M |  China |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
5.75 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 24.04 | -2.69 % | $ 668 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 157.96 | -4.34 % | $ 7.83 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 196.47 | -0.85 % | $ 21.8 B | USA |
 |
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
9.32 M | $ 8.45 | - | $ 33.7 M | Israel |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
303 M | $ 84.9 | -3.63 % | $ 10.6 B | USA |
 |
PerkinElmer
PKI
|
1.33 B | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
10.6 M | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 238.6 | -2.47 % | $ 25.5 B |  Schweiz |
 |
NeoGenomics
NEO
|
88.3 M | $ 7.52 | -3.09 % | $ 963 M | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 8.82 | -3.61 % | $ 1.91 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 17.02 | -1.96 % | $ 381 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Personalis
PSNL
|
31.1 M | $ 6.57 | -10.31 % | $ 389 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 267.25 | -0.42 % | $ 22.2 B | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 6.48 | -1.22 % | $ 270 M | USA |
 |
Psychemedics Corporation
PMD
|
4.71 M | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
3.14 M | $ 26.48 | -2.65 % | $ 34.4 M | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 16.88 | -3.38 % | $ 899 M | USA |
 |
Quotient Limited
QTNT
|
59.5 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Syneos Health
SYNH
|
1.65 B | - | - | $ 4.46 B | USA |